Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

6.79
+0.37005.76%
Post-market: 6.790.00000.00%18:49 EDT
Volume:136.00K
Turnover:921.26K
Market Cap:83.06M
PE:-1.84
High:6.90
Open:6.51
Low:6.47
Close:6.42
Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.8%, Outperforms Competitors

Dow Jones
·
15 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.1%, Underperforms Competitors

Dow Jones
·
14 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
12 Mar

Corbus Pharmaceuticals Is Maintained at Buy by Jefferies

Dow Jones
·
12 Mar

Corbus Pharmaceuticals (CRBP) Gets a Buy from William Blair

TIPRANKS
·
12 Mar

Corbus Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
11 Mar

Corbus Pharmaceuticals Q4 EPS $(0.78) Beats $(1.20) Estimate

Benzinga
·
11 Mar

Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

GlobeNewswire
·
11 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Mar

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
06 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
06 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
05 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Slides 7.8%, Underperforms Competitors

Dow Jones
·
04 Mar

William Blair Initiates Corbus Pharmaceuticals at Outperform

MT Newswires Live
·
28 Feb

Corbus Pharmaceuticals Initiated at Outperform by William Blair

Dow Jones
·
28 Feb

Corbus Pharmaceuticals initiated with an Outperform at William Blair

TIPRANKS
·
28 Feb